24.03.2013 Views

LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals

LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals

LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

OECD SIDS <strong>LINEAR</strong> <strong>ALKYLBENZENE</strong> <strong>SULFONATE</strong> (<strong>LAS</strong>)<br />

Japanese); cited in: IPCS (1996); Environmental Health Criteria 169: Linear<br />

Alkylbenzene Sulfonates (<strong>LAS</strong>) and Related Compounds. WHO, Geneva,<br />

Switzerland.<br />

Reliability: 4 This study is assigned a reliability score of 4 because the original report<br />

was not available for review. However, the study was evaluated by IPCS<br />

prior to inclusion in their criteria document<br />

(r)<br />

Species/strain: rabbit/New Zealand white<br />

Sex: Female [X]; Male [ ]; Male/Female [ ]; No data [ ]<br />

Administration: Dermal<br />

Exposure period: 17 days (days 1 through 16 of gestation)<br />

Frequency of treatment: Daily<br />

Doses: 0.03, 0.3, or 3% (0.9, 9, or 90 mg/kg bw d)<br />

Control group: Yes [X]; No [ ]; No data [ ];<br />

Concurrent no treatment [X]; Concurrent vehicle [ ]; Historical [ ]<br />

NOAEL Maternal: 0.03% (0.9 mg/kg bw d)<br />

NOAEL teratogenicity: 3% (90 mg/kg bw d)<br />

Results: Maternal toxicity:<br />

At the high dose, local irritation was observed resulting in body weight loss<br />

and hypersensitivity (i.e., animals were increasingly irritable). The medium<br />

dose caused retarded body weight gain and hypersensitivity.<br />

Teratogenicity:<br />

At the medium and low dose, no differences were observed among the dose<br />

groups and the control group with respect to number of litters, viable young,<br />

litter weight, foetal weight, embryonic deaths, implantations, corpora lutea,<br />

pre and post implantation embryonic loss. The high dose was associated with<br />

slightly, but not significantly, higher foetal loss and lower litter size. The<br />

incidences of major malformations, minor visceral or skeletal anomalies, and<br />

skeletal variants were not different between controls and dose groups even at<br />

maternal toxic doses.<br />

Method: The dosage volume was 10 mL which was applied to an area of skin (12 x 20<br />

cm) from which the fur was removed. The nominal doses were 0.9, 9.0, and<br />

90 mg/kg bw/day. Thirteen rabbits per dose were used.<br />

GLP: Yes [ ] No [X] ? [ ]<br />

Test substance: <strong>LAS</strong><br />

Reference: Palmer, A.K., Readshaw, M.A. and Neuff, A.M. 1975b. Assessment of the<br />

teratogenic potential of surfactants (Part III) – Dermal application of <strong>LAS</strong><br />

and soap. Toxicology 4:171-181.<br />

Reliability: 2 Valid with restrictions<br />

5.10 OTHER RELEVANT INFORMATION<br />

(a)<br />

Type: Toxicokinetics<br />

Results:<br />

35 8<br />

S-<strong>LAS</strong> (15 x 10 cpm) was administered topically, once, onto the back skin<br />

of rats and guinea pigs. Absorption and distribution in major organs and<br />

blood were studied. Urine was collected 24 hours after topical application of<br />

the test substance. In the guinea pig, the amount of 35 S excreted in the urine<br />

was about 0.1% of the total administered dose. Organ distribution in the rat<br />

was about 5 times greater than in the guinea pig, and "relatively large<br />

amounts" of 35 S were noted in the liver and kidneys. Conclusion states that:<br />

"when 0.2 to 0.5% <strong>LAS</strong> was topically applied once, approximately 0.1 to<br />

0.6% was absorbed"; there was no accumulation in specific organs; the "test<br />

chemical was quickly excreted in the urine after being metabolized".<br />

<strong>UNEP</strong> PUBLICATIONS 303

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!